“We’ve got R&D corporate centers (HPC) in the U.S., France, Brazil, Singapore and Shanghai,” explained John Cherkauskas Jr., vice president, R&D for North America. “All together, we’ve built a global team of 41 dedicated scientists and engineers.”
The company even operates a Lab of the Future based in Bordeaux, France, where Rhodia has partnered with the French National Center for Scientific Research. The site hosts research scientists sent on temporary assignments from Rhodia’s worldwide centers, in addition to Ph.D. and post-doc students from universities.
“We have a diverse group of employees with outstanding formulation expertise,” said Rajesh Pazhianur, technical manager, home and personal care. “We can deliver extra benefits unlike any other company.”
This kind of dedication has helped Rhodia roll out an array of novel products and improve financial results as well. And Novecare is one of Rhodia’s growth engines. At press time, 2007 results had not been released, but David Klucsik, director of communications and public affairs, North America, noted that the company is well-positioned to gain market share around the world, especially in emerging markets.
“In 2006, we exceeded all the targets that we had set for ourselves back in 2003,” explained Mr. Klucsik. “Novecare is a big reason for that success.”